The association of GLP-1 receptor agonist use with survival and immune-related adverse events in patients receiving immune checkpoint inhibitors: A multi-institutional real-world analysis
MD simulations of apo GLP-1R MD simulations have been used to study the conformational dynamics of class B GPCRs and have provided valuable information regarding the molecular basis of receptor dynamics and ECD transitions between the inactive and active states 15,19
Wootten D, Reynolds CA, Smith KJ, Mobarec JC, Koole C, Savage EE, et al
Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus
10.1002/jcb.26292 118 ZhangY.LiM.WangW.HeS
However, most experts worldwide agree that, based on available research, GLP-1 treatments are likely to be helpful for people with MASH who also have type 2 diabetes or obesity